Results 81 to 90 of about 22,830 (226)
Targeting ALK, ROS1, and BRAF Kinases [PDF]
Cancer cells demonstrate numerous genetic aberrations. Despite this genetic complexity, it is hypothesized that cancer cells are often addicted to a single oncogenic driver such that inhibition of this single target would lead to cell death.1 Data collected from patients with adenocarcinoma by the Lung Cancer Mutation Consortium (LCMC) demonstrate a ...
Doebele, Robert C., Camidge, D. Ross
openaire +2 more sources
This nationwide survey reveals that comprehensive multigene testing for advanced NSCLC has rapidly expanded in Japan, steadily increasing the use of targeted therapies for rare oncogenic drivers. Despite these diagnostic advancements, approximately 30% of patients consistently remain untested, highlighting a persistent clinical gap in real‐world ...
Satoshi Ikeda +9 more
wiley +1 more source
Figure 6 Comprehensive genomic profiling identified additional actionable alterations in a substantial proportion of patients with non‐squamous NSCLC despite previously identified driver alterations, with some findings leading to subsequent matched targeted therapies.
Yoshihiro Masui +15 more
wiley +1 more source
Cytology‐First Diagnostic Workflow for Melanoma of Unknown Primary With Molecular Profiling
Cytology‑first diagnostic workflow for melanoma of unknown primary. Fine‑needle aspiration of an enlarged lymph node enables rapid cytologic evaluation and immunocytochemical confirmation of melanocytic lineage (SOX10). This early cytologic diagnosis facilitates timely surgical excision and comprehensive genomic profiling, supporting integrated ...
Hong Yu +3 more
wiley +1 more source
Background ROS1 rearrangements are validated drivers in lung cancer, which have been identified in a small subset (1–2%) of patients with non-small cell lung cancer (NSCLC). To date, 18 fusion genes of ROS1 have been identified in NSCLC.
Shuguang Xu +6 more
doaj +1 more source
ROS1-fusion protein induces PD-L1 expression via MEK-ERK activation in non-small cell lung cancer
Introduction Despite some of the oncogenic driver mutations that have been associated with increased expression of programmed death-ligand 1 (PD-L1), the correlation between PD-L1 expression and ROS1 fusion in NSCLC cells, especially for those with ...
Zheng Liu +11 more
doaj +1 more source
DNA methylome responses to biotic and abiotic stress in Arabidopsis thaliana: A multi‐study analysis
Sixteen Arabidopsis thaliana Whole‐Genome Bisulfite Sequencing datasets have been analysed to reveal common and stress‐specific DNA methylation responses. Although global methylation levels remained stable, specific DMRs varied according to the type of stress and genomics context.
R. Behl +7 more
wiley +1 more source
While current guidelines recommend the analysis of established cancer driver genes in brain metastases, little is known about its real‐life implementation. This multicenter study revealed an upward trend in the profiling rates of surgically treated brain metastases over the past decade, with up to 60% of brain metastases samples undergoing analysis ...
Maria Nikolaeva +25 more
wiley +1 more source
Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma [PDF]
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give ...
Lee, Kyung-Hun +11 more
core +1 more source
ABSTRACT Background The emergence of personalized therapy and molecular sequencing has significantly transformed the management of advanced non–small cell lung carcinoma (NSCLC). Supernatants obtained from fine needle aspiration (FNA) have been shown to be a reliable source of high‐quality nucleic acid for molecular testing.
Adeyinka Akinsanya +9 more
wiley +1 more source

